• William Blair Reaffirms "Outperform" Rating for Verve Therapeutics (NASDAQ:VERV)

    المصدر: Buzz FX / 22 فبراير 2025 22:26:17   America/New_York


    William Blair Reaffirms "Outperform" Rating for Verve Therapeutics (NASDAQ:VERV) Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Verve Therapeutics ( NASDAQ:VERV - Get Free Report ) 's stock had its "outperform" rati
    Read more...
شارك على،